中国急性缺血性卒中多层面质量改进干预的成本效果分析
本研究采用短期决策树模型与长期马尔可夫模型,评估中国急性缺血性卒中多层面质量改进干预的成本效果。
要点
- 多层面质量改进干预在长期内每获得一个QALY需额外花费6138元人民币(940美元)。
- 干预在2017年中国人均GDP 1倍支付意愿阈值下,99.9%模拟运行中具有高成本效果。
- 该结果可为中低收入国家及高收入国家服务不足地区提供参考。
核心结论
- 在中国,针对卒中照护的多层面质量改进干预具有高成本效果。
研究设计与样本
- 采用短期决策树模型和长期马尔可夫模型分析成本效果。
- 数据来自近期临床试验和已发表文献。
主要发现
- 与常规照护相比,干预在长期内获得0.246个QALY,额外成本为1510元人民币(230美元),每QALY成本为6138元人民币(940美元)。
关键数值与推荐
- 长期每QALY成本为6138元人民币(940美元)。
临床怎么用
- 支持在中国推广多层面质量改进干预以改善急性缺血性卒中照护。
- 结果可为中低收入国家及高收入国家服务不足地区提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Multifaceted quality improvement interventions of stroke care have been shown to improve hospital personnel adherence to evidence-based performance measures and subsequent stroke outcomes. This study aimed to evaluate the cost-effectiveness of a multifaceted quality improvement intervention for stroke care in China, the world's largest low- and middle-income country. Methods- A short-term decision tree model and a long-term Markov model were used to analyze the cost-effectiveness of a multifaceted quality improvement intervention for patients with acute ischemic stroke. Outcomes, transition probability, and cost data were obtained from a recent clinical trial and the published literature. The benefit of the intervention was assessed by the costs per quality-adjusted life-years gained in the short- and long-term. One-way and probabilistic sensitivity analyses were performed to assess the uncertainty of the findings. Results- Compared with usual care, a multifaceted quality improvement intervention for stroke care was found to be cost-effective in the first year and highly cost-effective from the second year onward. In the long-term, the intervention yielded a lifetime gain of 0.246 quality-adjusted life-years at an additional cost of Chinese Yuan Renminbi 1510 (US $230), resulting in a cost of Chinese Yuan Renminbi 6138 (US $940) per quality-adjusted life-year gained. Probabilistic sensitivity analysis indicated that the intervention was highly cost-effective in 99.9% of the simulation runs at a willingness-to-pay threshold of Chinese Yuan Renminbi 59 700 (1× gross domestic product per capita of China in 2017, US $9200) per quality-adjusted life-year. Conclusions- A multifaceted quality improvement intervention for stroke care was highly cost-effective in China. The results of this study may be used as a reference for delivering such interventions in low- and middle-income countries and in underserved areas of high-income countries.
引用
- Pan Y, Zhang L, Li Z, et al. Cost-Effectiveness of a Multifaceted Quality Improvement Intervention for Acute Ischemic Stroke in China. Stroke. 2020. PMID: 32019480. doi:10.1161/STROKEAHA.119.027980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。